Back to results
US 2020/0281933 A1Published application
Pleuromutilin derivatives for the treatment of diseases mediated by microbes
AssigneeNabriva Therapeutics AG
InventorsRosemarie Mang, Werner Heilmayer, Rudolf Badegruber, Dirk Strickmann, Rodger Novak, Mathias Ferencic, Atchyuta Rama Chandra Murty Bulusu
Life of this patent
Estimating the term…
Abstract
Pleuromutilin derivative compounds of the following formula (I), and uses thereof for the treatment of diseases mediated by microbes, are disclosed:
Claims12
A compound of formula (I)
- wherein
- n is 0 to 4;
- m is 0 or 1 with the proviso that the sulphur atom and R3 are in vicinal position (if m=0 then R3 is in position 2′, and if m=1 then R3 is on position 1′);
- R is ethyl or vinyl;
- R1 is hydrogen or (C1-6)alkyl,
- R2 is hydrogen or
- (C3-6)cycloalkyl, or
- unsubstituted (C1-6)alkyl, or
- (C1-6)alkyl substituted by one or more of
- hydroxy;
- preferably one or two,
- methoxy,
- halogen,
- (C3-6)cycloalkyl, or
- R1 and R2 together with the nitrogen atom to which they are attached Colin a 5 to 7 membered heterocyclic ring containing at least 1 nitrogen atom or 1 nitrogen and 1 additional heteroatoms e.g. selected from N or O, or
- R1 is hydroxy and R2 is formyl;
- R3 is OH, OR4, a halogen atom, or
- with the proviso that R3 is bound to 2′R3 represents —O—(CH2)p—O— with p is 2 or 3;
- R4 is unsubstituted (C1-6)alkyl or (C3-6)cycloalkyl.
16 more elements
Dependencies are inferred from the claim text.